Clinical Trial: Genetic Analysis Between Charlotte's Web Responders Versus Non- Responders in a Dravet Population

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: Genetic Analysis Between Charlotte's Web Responders Versus Non- Responders in a Dravet Population

Brief Summary: There is tremendous curiosity about medical marijuana and the treatment of epilepsy. In a specific genetic epilepsy known as Dravet Syndrome, a mutation occurs affecting the SCN1A gene. A specific strain of marijuana known as Charlotte's Web, available in Colorado, may have activity in this catastrophic epilepsy syndrome. Anecdotal reports suggest both success and lack of response with this therapy. Genetic analysis of the differences between Dravet responders and non-responders may prove useful for identifying patients likely to be helped by this therapy, as well as shed light on the putative mechanisms by which marijuana may exert any antiepileptic effect.